Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

sales@dingminpharma.com

86-311-67591193

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
HomeProductsAPIs And IntermediatesNintedanib IntermediatesAPI Nintedanib powder CAS No 656247-17-5 manufacture

API Nintedanib powder CAS No 656247-17-5 manufacture

Payment Type:
L/C,T/T,D/P
Incoterm:
FOB,CIF
Min. Order:
0.01 Kilogram
Transportation:
Ocean,Air
Port:
Shanghai,Shenzhen,Qingdao
Share:
  • Product Description
Overview
Product Attributes

Model No.DM 656247-17-5

FunctionSpecialist Drugs

CertificationGMP

Grade StandardMedicine Grade

TypeChemical Reagent

StateSolid

VolatileNot Volatile

Purity99%

AppearenceYellow Powder

Supply Ability & Additional Information

PackagingAs required

TransportationOcean,Air

PortShanghai,Shenzhen,Qingdao

Payment TypeL/C,T/T,D/P

IncotermFOB,CIF

Packaging & Delivery
Selling Units:
Kilogram
Package Type:
As required

Manufactuere supply API Nintedanib powder CAS No 656247-17-5:

Name : Nintedanib, CAS 656247-17-5
Chemical name :

methyl (3Z)-3-[[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]anilino]-phenylmethylidene]-2-oxo-1H-indole-6-carboxylate Nintedanib

Key words : API; antineoplastic; treat idiopathic pulmonary fibrosis.
CAS NO.    : 656247-17-5

EINECS No:1592732-453-0
Molecular Formula : C31H33N5O4
Molecular Weight : 539.636 g/mol 

We are the manufacturer of Nintedanib and its Intermediates, high purity, low price, stock available


Nintedanib is an oral administrated triple tyrosine kinase inhibitors developed by Boehringer Ingelheim, Germany. Its targets include platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and basic fiber (BFGF), being able to also inhibit the activation of MAPK and Akt. At present, it is mainly used for cancer treatment, such as colorectal cancer, ovarian cancer and multiple myeloma. The study regarding to the respiratory diseases mainly focuses on the clinical treatment of advanced non-small cell lung cancer (NSCLC) and idiopathic pulmonary fibrosis (IPF). In June 2014, Boehringer Ingelheim has announced that the marketing authorization application of Nintedanib for the treatment of Idiopathic Pulmonary Fibrosis (IPF) had been confirmed by the European Medicines Agency (EMA) and been included in the accelerated approval list by the EMA.

Treatment of systemic sclerosis.
Treatment of idiopathic pulmonary fibrosis.
Argatef is indicated in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first line chemotherapy.


Our productions of Nintedanib Intermediates:

Nintedanib Intermediates


Picture of Nintedanib powder CAS No 656247-17-5:

Nintedanib powder CAS No 656247-17-5

Package & Shipping:

1. Preferentially DHL or FedEx for quantity less than 50KG; Air shipping for 100KG above; Sea shipping for quantity over 500KG.
2. We can offer the complete package from concept to delivery; arranging everything up until products arrive at your own door or distribution hub.
    Delivery can be offered.
  - Utilizing your own freight-forwarder
  - FOB to a port in China
  - CIF to a port near you

Nintedanib powder


Our Service:

1. Supply high quality products with reasonable prices for pharmaceutical factory. 
2. In time delivery, Packing pictures and loading video before loading.
3. Various documents(COA, MSDS, ROS, MOA etc.) and factory audit available. 
4. Pre-sale consultation and post-sale service available.
5. Provide market informations to make customers fully informed.


Company Information:

Shijiazhuang Dingmin Pharmaceutical Sciences Co., Limited is a professional company ocusing on the R&D, production, marketing and technical service of APIs and Pharmaceutical Intermediates. We have a R&D center and two plants in Shijiazhuang, Hebei Province. Our Products include Active Pharmaceutical Ingredients (API), pharmaceutical and Agrochemical Intermediates and chiral compounds. We have won the trust of a wide range of customers/partners in the industry. Our major products are antineoplastic, cardiovascular and Antibiotics and their intermediates.
In order to maintain continuous innovation and R & D capability, we maintain long-term and close cooperation with many research institutions and universities, Our co-production plants are located in Anhui, Jiangsu, Zhejiang and Inner Mongolia. The products have been sold to Europe, America, Southeast Asia and other countries and regions
Having upholding the " integrity, profession , innovation, win-win" as business philosophy, we believe that we are able to be stronger and stronger because of the excellent quality, favorable price and full-hearted service. We would like to sincerely welcome friends from all sectors to co-create a brilliant tomorrow together.

CAS No 656247-17-5


Product Categories : APIs And Intermediates > Nintedanib Intermediates

Email to this supplier
  • *Subject:
  • *To:
    Ms. Lily
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
HomeProductsAPIs And IntermediatesNintedanib IntermediatesAPI Nintedanib powder CAS No 656247-17-5 manufacture
Send Inquiry
*
*

Related Products List

Home

Product

Phone

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send